Protein shedding in urothelial bladder cancer: prognostic implications of soluble urinary EGFR and EpCAM - Bryan, R T; Regan, H L; Pirrie, S J; Devall, A J; Cheng, K K; Zeegers, M P; James, N D; Knowles, M A; Ward, D G (British journal of cancer, 2015)
Keywords: 631/61/475; 692/53/2422; 692/699/67/589/1336; Aged; Aged, 80 and over; Antigens, Neoplasm - urine; Biomarkers, Tumor - urine; Biomedical and Life Sciences; Biomedicine; Bladder cancer; Cancer Research; Case-Control Studies; Cell Adhesion Molecules - urine; Cell Line, Tumor; Drug Resistance; Epidemiology; Epithelial Cell Adhesion Molecule; Female; Humans; Male; Molecular Diagnostics; Molecular Medicine; Oncology; Prognosis; Receptor, Epidermal Growth Factor - urine; Urinary Bladder Neoplasms - diagnosis; Urinary Bladder Neoplasms - urine; EpCAM; urine; prognosis; bladder cancer; EGFR